María José Valenzuela1, Bárbara Münzenmayer2, Tomás Osorio2, Marcelo Arancibia3, Eva Madrid3. 1. Departamento de Medicina Interna, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Chile. 2. Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Chile. 3. Centro Interdisciplinario de Estudios en Salud, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Chile.
Abstract
BACKGROUND: Patients with diabetes mellitus show a higher risk of developing depressive symptoms when compared to healthy people, hampering the management and prognosis of both diseases. However, national studies on the topic are scarce. AIM: To study the frequency and severity of depressive symptoms in patients with type 2 diabetes. MATERIAL AND METHODS: Beck Depression Inventory-IA and Morisky Green Levine scale were administered to diabetic patients under control at a primary care center. Pharmacological compliance was evaluated using glycosylated hemoglobin levels obtained from their clinical records. RESULTS: We included 323 patients aged 64 ± 12 years (49% women). The frequency of depressive symptoms was 34.7%. Compared with their counterparts without depressive symptoms, patients with depression showed higher glycosylated hemoglobin levels (7.2 ± 1.7 and 6.7 ± 1.3% respectively), a higher frequency of non-compliance with treatment (63 and 43% respectively) and a higher frequency of metabolic decompensation (38 and 23% respectively). Depressive symptomatology was more common among women. CONCLUSIONS: Patients with type 2 diabetes mellitus and depressive symptoms exhibit a poorer treatment compliance and worse metabolic control as compared to their non-depressive counterparts.
BACKGROUND:Patients with diabetes mellitus show a higher risk of developing depressive symptoms when compared to healthy people, hampering the management and prognosis of both diseases. However, national studies on the topic are scarce. AIM: To study the frequency and severity of depressive symptoms in patients with type 2 diabetes. MATERIAL AND METHODS:Beck Depression Inventory-IA and Morisky Green Levine scale were administered to diabeticpatients under control at a primary care center. Pharmacological compliance was evaluated using glycosylated hemoglobin levels obtained from their clinical records. RESULTS: We included 323 patients aged 64 ± 12 years (49% women). The frequency of depressive symptoms was 34.7%. Compared with their counterparts without depressive symptoms, patients with depression showed higher glycosylated hemoglobin levels (7.2 ± 1.7 and 6.7 ± 1.3% respectively), a higher frequency of non-compliance with treatment (63 and 43% respectively) and a higher frequency of metabolic decompensation (38 and 23% respectively). Depressive symptomatology was more common among women. CONCLUSIONS:Patients with type 2 diabetes mellitus and depressive symptoms exhibit a poorer treatment compliance and worse metabolic control as compared to their non-depressive counterparts.
Authors: Antonia Raya-Tena; María Isabel Fernández-San-Martin; Jaume Martin-Royo; Rocío Casañas; Glòria Sauch-Valmaña; Cèlia Cols-Sagarra; Elena Navas-Mendez; Roser Masa-Font; Marc Casajuana-Closas; Quintí Foguet-Boreu; Eva María Fernández-Linares; Jacobo Mendioroz-Peña; Susana González-Tejón; Luis Miguel Martín-López; María Francisca Jiménez-Herrera Journal: Int J Environ Res Public Health Date: 2021-03-13 Impact factor: 3.390